Editing Guidelines (section)

=== Oncology ===

==== Prostate ====

* [[CUA: Castrate-resistant Prostate Cancer (2021)|Castrate-resistant Prostate Cancer (2021)]]
* [[CUA: Androgen Deprivation Therapy: Adverse Events & Management (2021)|Androgen Deprivation Therapy: Adverse Events & Management (2021)]]
* [[CUA: Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)|Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)]]
* [[CUA: Testosterone Suppression (2018)|Testosterone Suppression (2018)]]
* [[CUA: Prostate Cancer Screening (2017)|Prostate Cancer Screening (2017)]]
* [[Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)]]
* [[CUA: Prostate Cancer Active Surveillance (2015)|Prostate Cancer Active Surveillance (2015)]]

==== Bladder ====

* [[CUA & AUA: Non-muscle Invasive Bladder Cancer (2021 CUA & 2020 AUA)|Non-muscle Invasive Bladder Cancer (2021)]]
* [[CUA: Advanced and Metastatic Urothelial Cancer (2019)|Advanced and Metastatic Urothelial Cancer (2019)]]
* [[CUA: Muscle-invasive Bladder Cancer (2019)|Muscle-invasive Bladder Cancer (2019)]]
* [[CUA: Asymptomatic Microscopic Hematuria (2008)|Asymptomatic Microscopic Hematuria (2008)]]

==== Kidney ====

* [[CUA: Follow-up Localized RCC (2018)|Follow-up Localized RCC (2018)]]
* [[CUA: Cystic Renal Lesions (2017)|Cystic Renal Lesions (2017)]]
* [[CUA: Small Renal Masses (2015)|Small Renal Masses (2015)]]
* [[CUA: Surgical Management of RCC (2014)|Surgical Management of RCC (2014)]]
* [[CUA: RCC Genetic Screening (2013)|RCC Genetic Screening (2013)]]